Third positive trial sets up filings for AbbVie’s Rinvoq in Crohn’s

AbbVie’s would-be blockbuster Rinvoq has notched up another positive trial in Crohn’s disease, showing that it can achieve clinical remission over a full year when used as a maintenance therapy.